Danny Gardner

Danny Gardner is the Social Intelligence Lead, US Digital Analytics at GlaxoSmithKline (GSK), a multi-national pharmaceutical company, where he is responsible for building an in-house social intelligence capability. While his responsibilities are constantly evolving, he regularly executes social listening, data analytics, and business intelligence reporting across GSK’s world-renowned consumer healthcare brands, such as Advil and Sensodyne, to inform and drive their enterprise digital marketing strategy.

Previously, he held the same role at Pfizer where he was acquired as part of the $12B consumer healthcare joint venture between them and GSK. Danny began his full-time career with W2O Group, an integrated healthcare marketing and communications agency, where he held cross-functional roles in data science, social listening, market research, and applied analytics.

On the Social Media Day PHL Board, Danny serves as the Chair of the Fundraising Committee.  Social Media Day Philadelphia has been a popular event in the region for years, bringing together professionals from all walks of life to network, geek out, and just have fun.  Danny joined the Board of Directors to champion those who come from a “non-traditional” social background and to celebrate our achievements as an industry.  Furthermore, according to Danny, “education is one of the most powerful tools we have as an industry, one easily sharpened by the platform that Social Media Day provides us with.  I joined the board of directors to make sure that whether you come from an agency, client, non-profit, university, or a 20-year career as a freelancer, everyone has the opportunity to be heard.”

Danny holds a BA in economics from the University of Maryland, College Park and an MBA in business analytics & marketing from American University’s Kogod School of Business.